Gene Therapy for Leber Congenital Amaurosis

The first AAV-mediated RPE gene therapy to restore visual function was obtained in a canine model of Leber Congenital Amaurosis (LCA), a severe form of autosomal recessive, childhood-onset retinal dystrophy 1;2. Humans with LCA are born with significant vision deficits and usually lose all vision within ten years